BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 6692414)

  • 1. Normalization of in vitro sensitivity testing of human tumor clonogenic cells.
    Hug V; Thames H; Blumenschein GR; Spitzer G; Drewinko B
    Cancer Res; 1984 Mar; 44(3):923-8. PubMed ID: 6692414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Human tumor clonogenic assay in human breast cancer].
    Kobayashi T; Kuraishi Y; Aiba K; Inoue K
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1566-72. PubMed ID: 3927846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential cytotoxic activity of chemotherapy agents on colony-forming cells from human tumors and normal bone marrow in vitro.
    Ajani JA; Blaauw AA; Spitzer G; Baker FL; Tomasovic B; Umbach G; Thielvoldt D; Zander AR; Dicke KA
    Exp Hematol; 1985; 13 Suppl 16():95-100. PubMed ID: 2580731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-survival curves of cis-platinum, melphalan, and velban in human granulocyte/macrophage progenitor cells.
    Umbach GE; Singletary SE; Tomasovic B; Spitzer G; Hug V; Drewinko B
    Int J Cell Cloning; 1984 Nov; 2(6):335-40. PubMed ID: 6542929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro drug-sensitivity test using human tumor clonogenic assay in lung cancer patients].
    Ohnoshi T; Hiraki S
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1582-7. PubMed ID: 3927847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro growth and drug sensitivity of tumor colony-forming units from human tumor xenografts.
    Taetle R; Koessler AK; Howel SB
    Cancer Res; 1981 May; 41(5):1856-60. PubMed ID: 7214353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro drug sensitivity studies of colony-forming units in culture in chronic myelocytic leukemia: lack of specificity between chronic-phase patients and normal donors.
    Kirshner J; Preisler HD
    Cancer Res; 1983 Dec; 43(12 Pt 1):6094-5. PubMed ID: 6580067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sensitivity testing of anticancer drugs using the human tumor clonogenic assay].
    Hiraki S; Ohnoshi T; Kishimoto N; Mori K; Nishii K; Yonei T; Yamashita H; Kimura I
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1208-13. PubMed ID: 3729443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of in vitro chemosensitivity assays: human tumor clonogenic and scintillation assay].
    Tanigawa N; Morimoto H; Akita T; Inoue H; Tanaka T
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1176-84. PubMed ID: 3729439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A murine model to evaluate the ability of in vitro clonogenic assays to predict the response to tumors in vivo.
    Mirabelli CK; Sung CM; McCabe FL; Faucette LF; Crooke ST; Johnson RK
    Cancer Res; 1988 Oct; 48(19):5447-54. PubMed ID: 3046738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a combined treatment with ASTA-Z 7654 and VP16-213 in vitro in eradicating clonogenic tumor cells from human bone marrow.
    De Fabritiis P; Pulsoni A; Sandrelli A; Simone F; Amadori S; Meloni G; Mandelli F
    Bone Marrow Transplant; 1987 Oct; 2(3):287-98. PubMed ID: 3502785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo.
    Teicher BA; Holden SA; Eder JP; Brann TW; Jones SM; Frei E
    Cancer Res; 1989 Nov; 49(21):5994-8. PubMed ID: 2790813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of hematologic toxicity of antineoplastic agents with their effects on bone marrow stem cells: interspecies studies using an in vivo assay.
    Marsh JC
    Exp Hematol; 1985; 13 Suppl 16():16-22. PubMed ID: 3987835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cytostatic drugs and 40.5 degrees C hyperthermia on human bone marrow progenitors (CFU-C) and human clonogenic tumor cells implanted into mice.
    Neumann HA; Fiebig HH; Löhr GW; Engelhardt R
    J Natl Cancer Inst; 1985 Dec; 75(6):1059-66. PubMed ID: 2999496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapeutic sensitivity of normal and leukemic hematopoietic progenitor cells to N-[4-(9-acridinylamino)-3-methoxyphenyl]-methanesulfonamide, a new anticancer agent.
    Spiro TE; Socquet M; Delforge A; Stryckmans P
    J Natl Cancer Inst; 1981 Apr; 66(4):615-8. PubMed ID: 6939909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bovine seminal ribonuclease exerts selective cytotoxicity toward neuroblastoma cells both sensitive and resistant to chemotherapeutic drugs.
    Cinatl J; Cinatl J; Kotchetkov R; Matousek J; Woodcock BG; Koehl U; Vogel JU; Kornhuber B; Schwabe D
    Anticancer Res; 2000; 20(2A):853-9. PubMed ID: 10810366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
    Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An in vitro chemotherapy sensitivity test on leukemic colony-forming cells (L-CFU) and its clinical evaluation].
    Moriyama Y; Urushiyama M; Hirosawa H; Koyama S; Takai K; Fujiwara M; Kishi K; Takahashi M; Sakai C; Sanada M; Shibata A
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1749-54. PubMed ID: 7184371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug and hormone sensitivity of estrogen receptor-positive and -negative human breast cancer cells in vitro.
    Goldenberg GJ; Froese EK
    Cancer Res; 1982 Dec; 42(12):5147-51. PubMed ID: 7139616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of the ability to purge tumor from murine bone marrow using clonogenic assays.
    Jones RJ; Colvin OM; Sensenbrenner LL
    Cancer Res; 1988 Jun; 48(12):3394-7. PubMed ID: 3285994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.